Editas Medicine Inc - Company Profile
Powered by
All the data and insights you need on Editas Medicine Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Editas Medicine Inc Strategy Report
- Understand Editas Medicine Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Editas Medicine Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US20220273818A1 | Application | COMPOSITIONS AND METHODS FOR TREATING CEP290-ASSOCIATED DISEASE | A61K48/0008; A61K48/0058; A61K48/0066; A61K48/0091; A61P27/02 | September 01, 2022 |
EP4047092A1 | Application | CAS9-FUSIONSMOLEKÜLE, GENEDITIERUNGSSYSTEME UND VERFAHREN ZUR VERWENDUNG DAVON | C07K19/00; C07K2319/80; C12N15/10; C12N15/102; C12N15/11; C12N15/63; C12N15/907; C12N2310/20; C12N2800/80; C12N9/22; C12Y301/00 | August 24, 2022 |
IL293643A | Application | Modified cells and methods for the treatment of hemoglobinopathies | A61K35/28; A61K48/005; A61P7/06; C07K14/82; C12N15/102; C12N15/113; C12N15/907; C12N2310/20; C12N2310/313; C12N2310/315; C12N2510/00; C12N5/0647; C12N9/22 | August 01, 2022 |
IL293946A | Application | Engineered cells for therapy | A61K35/17; C07K14/4703; C07K14/705; C07K14/71; C12N2501/15; C12N2501/602; C12N2501/603; C12N2501/604; C12N2501/605; C12N2501/606; C12N2501/608; C12N2501/65; C12N2506/1307; C12N2506/45; C12N5/0646 | August 01, 2022 |
AU2016276702B2 | Grant | CRISPR/CAS-related methods and compositions for improving transplantation | A61K35/28; A61P19/00; A61P3/00; A61P31/18; A61P35/00; A61P35/02; A61P37/04; A61P7/00; A61P7/06; C07K14/70539; C12N15/102; C12N15/11; C12N15/111; C12N15/86; C12N2310/20; C12N2510/00; C12N5/0647; C12N9/22; G16B25/10; G16B40/00; G16B50/00 | July 28, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer